Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma

Surgery followed by chemoradiation and adjuvant chemotherapy is standard of care for patients with a glioblastoma (GBM). Due to its limited benefit, an upfront method to predict dismal outcome would prevent unnecessary toxic treatment. We searched for a predictive blood derived biomarker in a cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: van Linde, Myra E., van der Mijn, Johannes C., Pham, Thang V., Knol, Jaco C., Wedekind, Laurine E., Hovinga, Koos E., Aliaga, Esther Sanchez, Buter, Jan, Jimenez, Connie R., Reijneveld, Jaap C., Verheul, Henk M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Laboratory Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992035/
https://www.ncbi.nlm.nih.gov/pubmed/27444431
http://dx.doi.org/10.1007/s11060-016-2178-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992035/
https://www.ncbi.nlm.nih.gov/pubmed/27444431
http://dx.doi.org/10.1007/s11060-016-2178-x

Ejemplares similares